NDC 42571-369 – Roflumilast

Roflumilast 250 ug/1 · Tablet · Oral

Human Prescription Drug

Product NDC42571-369

Product details

Brand name
Roflumilast
Generic name
Roflumilast
Labeler
Micro Labs Limited
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA208180
Marketed since
May 1, 2023
Listing expires
December 31, 2026
Pharmacologic class
Phosphodiesterase 4 Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Roflumilast →

Package NDC codes (5)

Package NDCDescriptionSince
42571-369-05500 TABLET in 1 BOTTLE (42571-369-05)May 1, 2023
42571-369-1110 BLISTER PACK in 1 CARTON (42571-369-11) / 10 TABLET in 1 BLISTER PACK (42571-369-32)May 1, 2023
42571-369-3030 TABLET in 1 BOTTLE (42571-369-30)May 1, 2023
42571-369-8328 TABLET in 1 BOTTLE (42571-369-83)May 1, 2023
42571-369-9090 TABLET in 1 BOTTLE (42571-369-90)May 1, 2023

Other Roflumilast products